Shionogi & Co., Ltd. (4507.T)
JPY 2457.0
(1.84%)
JPY 2457.0
(1.84%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 162.03 Billion JPY | -12.4% |
| 2022 | 184.96 Billion JPY | 61.99% |
| 2021 | 114.18 Billion JPY | 2.08% |
| 2020 | 111.85 Billion JPY | -8.46% |
| 2019 | 122.19 Billion JPY | -7.96% |
| 2018 | 132.75 Billion JPY | 21.95% |
| 2017 | 108.86 Billion JPY | 29.79% |
| 2016 | 83.87 Billion JPY | 25.78% |
| 2015 | 66.68 Billion JPY | 51.35% |
| 2014 | 44.06 Billion JPY | 5.33% |
| 2013 | 41.83 Billion JPY | -37.31% |
| 2012 | 66.72 Billion JPY | 146.22% |
| 2011 | 27.1 Billion JPY | 35.33% |
| 2010 | 20.02 Billion JPY | -48.15% |
| 2009 | 38.62 Billion JPY | 146.63% |
| 2008 | 15.66 Billion JPY | -37.52% |
| 2007 | 25.06 Billion JPY | 34.79% |
| 2006 | 18.59 Billion JPY | -18.21% |
| 2005 | 22.73 Billion JPY | 20.02% |
| 2004 | 18.94 Billion JPY | 759.44% |
| 2003 | 2.2 Billion JPY | -62.67% |
| 2002 | 5.9 Billion JPY | -30.18% |
| 2001 | 8.45 Billion JPY | -32.96% |
| 2000 | 12.61 Billion JPY | -1.97% |
| 1999 | 12.86 Billion JPY | 31.21% |
| 1998 | 9.8 Billion JPY | 2.48% |
| 1997 | 9.57 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 52.49 Billion JPY | 71.35% |
| 2024 Q1 | 30.63 Billion JPY | -11.98% |
| 2023 Q1 | 42.56 Billion JPY | 56.27% |
| 2023 Q3 | 36.62 Billion JPY | -23.74% |
| 2023 Q2 | 48.03 Billion JPY | 12.85% |
| 2023 FY | 162.03 Billion JPY | -12.4% |
| 2023 Q4 | 34.8 Billion JPY | -4.97% |
| 2022 Q2 | 22.54 Billion JPY | -35.08% |
| 2022 FY | 184.96 Billion JPY | 61.99% |
| 2022 Q4 | 27.23 Billion JPY | -72.89% |
| 2022 Q1 | 34.72 Billion JPY | -19.6% |
| 2022 Q3 | 100.46 Billion JPY | 345.67% |
| 2021 Q4 | 43.18 Billion JPY | 141.68% |
| 2021 Q3 | 17.86 Billion JPY | -14.47% |
| 2021 Q2 | 20.89 Billion JPY | -35.19% |
| 2021 FY | 114.18 Billion JPY | 2.08% |
| 2021 Q1 | 32.23 Billion JPY | 25.03% |
| 2020 FY | 111.85 Billion JPY | -8.46% |
| 2020 Q1 | 21.53 Billion JPY | -31.3% |
| 2020 Q2 | 27.84 Billion JPY | 29.29% |
| 2020 Q3 | 36.69 Billion JPY | 31.78% |
| 2020 Q4 | 25.78 Billion JPY | -29.73% |
| 2019 Q1 | 24.41 Billion JPY | -36.44% |
| 2019 Q2 | 27.25 Billion JPY | 11.61% |
| 2019 Q3 | 39.87 Billion JPY | 46.33% |
| 2019 FY | 122.19 Billion JPY | -7.96% |
| 2019 Q4 | 31.34 Billion JPY | -21.39% |
| 2018 Q2 | 26 Billion JPY | -18.46% |
| 2018 Q4 | 38.41 Billion JPY | 5.4% |
| 2018 FY | 132.75 Billion JPY | 21.95% |
| 2018 Q1 | 31.89 Billion JPY | 9.45% |
| 2018 Q3 | 36.44 Billion JPY | 40.16% |
| 2017 Q3 | 29.39 Billion JPY | -14.38% |
| 2017 Q2 | 34.32 Billion JPY | 114.4% |
| 2017 Q1 | 16.01 Billion JPY | -2.01% |
| 2017 FY | 108.86 Billion JPY | 29.79% |
| 2017 Q4 | 29.13 Billion JPY | -0.86% |
| 2016 FY | 83.87 Billion JPY | 25.78% |
| 2016 Q2 | 18.66 Billion JPY | 48.87% |
| 2016 Q1 | 12.53 Billion JPY | -49.89% |
| 2016 Q3 | 36.34 Billion JPY | 94.74% |
| 2016 Q4 | 16.33 Billion JPY | -55.04% |
| 2015 FY | 66.68 Billion JPY | 51.35% |
| 2015 Q3 | 20.28 Billion JPY | 72.93% |
| 2015 Q2 | 11.72 Billion JPY | 21.46% |
| 2015 Q1 | 9.65 Billion JPY | -45.74% |
| 2015 Q4 | 25.01 Billion JPY | 23.34% |
| 2014 Q3 | 16.55 Billion JPY | 2804.41% |
| 2014 FY | 44.06 Billion JPY | 5.33% |
| 2014 Q2 | -612 Million JPY | -105.93% |
| 2014 Q1 | 10.32 Billion JPY | 124.59% |
| 2014 Q4 | 17.79 Billion JPY | 7.54% |
| 2013 Q4 | 4.59 Billion JPY | -70.97% |
| 2013 FY | 41.83 Billion JPY | -37.31% |
| 2013 Q1 | 10.84 Billion JPY | -71.75% |
| 2013 Q2 | 10.55 Billion JPY | -2.65% |
| 2013 Q3 | 15.83 Billion JPY | 49.92% |
| 2012 Q4 | 38.38 Billion JPY | 184.83% |
| 2012 FY | 66.72 Billion JPY | 146.22% |
| 2012 Q2 | 7.95 Billion JPY | 15.09% |
| 2012 Q1 | 6.91 Billion JPY | -18.96% |
| 2012 Q3 | 13.47 Billion JPY | 69.46% |
| 2011 Q2 | 4.42 Billion JPY | 17.01% |
| 2011 Q4 | 8.52 Billion JPY | -17.78% |
| 2011 Q1 | 3.78 Billion JPY | -41.83% |
| 2011 Q3 | 10.37 Billion JPY | 134.48% |
| 2011 FY | 27.1 Billion JPY | 35.33% |
| 2010 Q2 | 2.03 Billion JPY | -57.78% |
| 2010 Q1 | 4.82 Billion JPY | -63.14% |
| 2010 Q4 | 6.49 Billion JPY | -2.51% |
| 2010 Q3 | 6.66 Billion JPY | 227.2% |
| 2010 FY | 20.02 Billion JPY | -48.15% |
| 2009 Q4 | 13.09 Billion JPY | -6.12% |
| 2009 Q2 | 6.98 Billion JPY | 51.9% |
| 2009 Q1 | 4.6 Billion JPY | -4.33% |
| 2009 FY | 38.62 Billion JPY | 146.63% |
| 2009 Q3 | 13.94 Billion JPY | 99.5% |
| 2008 Q3 | -982 Million JPY | -115.23% |
| 2008 FY | 15.66 Billion JPY | -37.52% |
| 2008 Q4 | 4.8 Billion JPY | 589.71% |
| 2008 Q2 | 6.44 Billion JPY | 0.0% |
| 2007 FY | 25.06 Billion JPY | 34.79% |
| 2006 FY | 18.59 Billion JPY | -18.21% |
| 2005 FY | 22.73 Billion JPY | 20.02% |
| 2004 FY | 18.94 Billion JPY | 759.44% |
| 2003 FY | 2.2 Billion JPY | -62.67% |
| 2002 FY | 5.9 Billion JPY | -30.18% |
| 2001 FY | 8.45 Billion JPY | -32.96% |
| 2000 FY | 12.61 Billion JPY | -1.97% |
| 1999 FY | 12.86 Billion JPY | 31.21% |
| 1998 FY | 9.8 Billion JPY | 2.48% |
| 1997 FY | 9.57 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 3.2 Billion JPY | -4955.538% |
| Takeda Pharmaceutical Company Limited | 144.06 Billion JPY | -12.469% |
| Sumitomo Pharma Co., Ltd. | -314.96 Billion JPY | 151.443% |
| Wakamoto Pharmaceutical Co.,Ltd. | 108.95 Million JPY | -148607.312% |
| Nippon Shinyaku Co., Ltd. | 25.85 Billion JPY | -526.784% |
| Kaken Pharmaceutical Co., Ltd. | 8.02 Billion JPY | -1919.065% |
| Eisai Co., Ltd. | 42.4 Billion JPY | -282.083% |
| Morishita Jintan Co., Ltd. | 697 Million JPY | -23146.772% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.96 Billion JPY | -1059.926% |
| Mochida Pharmaceutical Co., Ltd. | 4.54 Billion JPY | -3463.448% |
| Fuso Pharmaceutical Industries,Ltd. | 1.37 Billion JPY | -11666.885% |
| Nippon Chemiphar Co., Ltd. | -180 Million JPY | 90116.667% |
| Tsumura & Co. | 16.7 Billion JPY | -869.833% |
| Kissei Pharmaceutical Co., Ltd. | 11.16 Billion JPY | -1351.882% |
| Torii Pharmaceutical Co., Ltd. | 4.11 Billion JPY | -3833.722% |
| Towa Pharmaceutical Co., Ltd. | 16.17 Billion JPY | -901.855% |
| Fuji Pharma Co., Ltd. | 3.43 Billion JPY | -4617.031% |
| Zeria Pharmaceutical Co., Ltd. | 7.73 Billion JPY | -1995.777% |
| KYORIN Holdings, Inc. | 5.32 Billion JPY | -2944.532% |
| Taiko Pharmaceutical Co.,Ltd. | -4.89 Billion JPY | 3410.789% |
| Daito Pharmaceutical Co.,Ltd. | 3.29 Billion JPY | -4817.451% |
| SymBio Pharmaceuticals Limited | -1.96 Billion JPY | 8354.972% |
| MedRx Co., Ltd | -932 Million JPY | 17485.193% |
| Mizuho Medy Co.,Ltd. | 3.77 Billion JPY | -4193.051% |
| Solasia Pharma K.K. | -1.11 Billion JPY | 14671.043% |
| Modalis Therapeutics Corporation | -2.39 Billion JPY | 6874.336% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 7.54 Billion JPY | -2047.515% |
| Sawai Group Holdings Co., Ltd. | 13.69 Billion JPY | -1083.133% |
| Cyfuse Biomedical K.K. | -589.21 Million JPY | 27599.487% |
| Toho Holdings Co., Ltd. | 20.65 Billion JPY | -684.383% |
| Koa Shoji Holdings Co.,Ltd. | 2.94 Billion JPY | -5399.371% |